Companion Animals

Dog Canine Cancer Immunotherapy

Immunotherapy for canine cancer is advancing with new targeted treatments offering improved outcomes with fewer side effects.

Key Facts

Cancer vaccines for melanoma are licensed in dogs and have extended survival in some cases
Immune checkpoint inhibitors targeting PD-1 are in clinical trials for canine cancer
Chimeric antigen receptor T-cell therapy is in early development for canine lymphoma
Combination immunotherapy with conventional chemotherapy shows improved response rates
Immunotherapy side effects differ from chemotherapy and require different monitoring protocols

Welfare Considerations

Dogs receiving effective cancer immunotherapy experience better disease control with potentially fewer debilitating side effects than conventional chemotherapy alone. Advances in veterinary oncology immunotherapy are improving both welfare and survival outcomes.

What You Can Do

Discuss immunotherapy options with a veterinary oncologist for dogs with applicable cancers
Enquire about clinical trial participation for dogs with cancers being studied in immunotherapy trials
Support veterinary cancer research that continues to advance immunotherapy treatment options